NEWS4 April 2014
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
US — IMS Health has priced its initial public offering at $20 a share, which stands to generate $1.3bn for the company and its private equity owners.
The healthcare data firm is putting 52m shares up for sale, with the resulting proceeds – around $1bn – earmarked for paying down existing long-term debt.
Meanwhile, the investment firms that took IMS private in a $5bn deal in 2010 will sell 13m shares – returning $260m to their coffers.
IMS filed for an IPO in January this year. The offering is expected to close on 9 April. Shares are expected to begin trading on the New York Stock Exchange (NYSE) today under the ticker symbol IMS.
Pictured is IMS CEO Ari Bousbib.
UPDATE: IMS shares opened at $22.18 on the NYSE this morning. As of 10.15am ET they were trading at $22.85.
Newsletter
Sign up for the latest news and opinion.
You will be asked to create an account which also gives you free access to premium Impact content.
“I wrote down a list of things that matter to me, in four categories – relationships, health, leisure and work. I d… https://t.co/MalB9p0olB
The number of profit warnings issued by UK-listed companies increased by 50% year-on-year in 2022, according to res… https://t.co/arjNoUjS2z
Cynozure bolsters US team https://t.co/eXWTCHXiKx #mrx #marketresearch
The world's leading job site for research and insight
Resources Group
Quant / Qual Insights specialist (akin to RM/AD) –Comms/NPD/Brand
£50,000–£60,000 + Excellent Benefits
Resources Group
Custom Analytics Analyst (Consumer) – Leading Specialist Insights Consultancy
£35,000
Resources Group
Associate Director – Mixed Methods – International Strategic Agency
£50,000–£60,000 + good benefits
Featured company
Town/Country: London
Tel: +44 (0)20 7490 7888
Kudos Research are leading providers of premium quality UK and International Telephone Data-Collection. Specialising in hard to reach B2B and Consumer audiences, we achieve excellent response rates and provide robust, actionable, verbatim-rich data. Methodologies include CATI, . . .
Related Articles
LAUNCHED Digital Ethnography 2023 23/03/23 9:30-16:35 ℹ️ Info + ticket: https://t.co/h3nN451Fgi Join us to ga… https://t.co/svXukMaxbS
The post-demographic consumerism trend means segments such age are often outdated, from @trendwatching #TrendSemLON
0 Comments